Advertisement

Topics

Foundation Medicine and Guardant Health Agree to Resolve False Advertising Lawsuit

16:05 EDT 13 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Foundation Medicine, Inc. (NASDAQ:FMI) and Guardant Health, Inc. announced an agreement to settle false advertising challenges that the companies had filed against each other under the Lanham Act related to advertising fo...

Other Sources for this Article

For Foundation Medicine:
Media:
Lee-Ann Murphy, 617-245-3077
pr@foundationmedicine.com
or
Investor:
Kimberly Brown, 617-418-2215
ir@foundationmedicine.com
or
For Guardant Health:
Media:
press@guardanthealth.com

NEXT ARTICLE

More From BioPortfolio on "Foundation Medicine and Guardant Health Agree to Resolve False Advertising Lawsuit"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...